LYR-220, Lyra’s second product candidate, is a long-acting anti-inflammatory therapy in development for CRS patients with and without polyps who have recurrent symptoms despite prior ethmoid sinus ...

Ethmoid sinus cancer is a rare form of cancer that originates in the sinuses, behind the upper nose and between the eyes. Treatment might include surgery, chemotherapy, or radiation therapy. Although ...

Endoscopic surgical approaches have transformed the management of sinus disorders by enabling direct visualisation and precise removal of obstructive or diseased tissue via the nasal cavity.

Endoscopic sinus surgery (ESS) has become the cornerstone of contemporary management for chronic sinonasal disorders, leveraging detailed endonasal anatomy and minimally invasive techniques to address ...

VenSure and Cube Join the Company’s Portfolio of Localized Drug Delivery Creating an Integrated Offering of ENT Technologies to Treat CRS As many as 1 in 8 adults in the United States suffer from CRS, ...